Childhood-onset systemic lupus erythematosus

被引:12
作者
Bader-Meunier, B
Quartier, P
Deschenes, G
Cochat, P
Haddad, E
Koné-Paut, I
Leblanc, T
Prieur, AM
Salomon, R
Bodemer, C
Lévy, M
机构
[1] Hop Bicetre, Serv Pediat Gen, F-94276 Le Kremlin Bicetre, France
[2] Hop Necker Enfants Malad, Serv Immunohematol & Rhumatol Pediat, F-75015 Paris, France
[3] Serv Nephrol Pediat, F-75012 Paris, France
[4] Hop Edouard Herriot, Serv Nephrol Pediat, F-69437 Lyon, France
[5] Hop Robert Debre, Serv Nephrol Pediat, F-75019 Paris, France
[6] Hop Nord Marseille, Serv Pediat, F-13915 Marseille, France
[7] Hop St Louis, Serv Hematol Pediat, F-75010 Paris, France
[8] Hop Necker Enfants Malad, Serv Dermatol, F-75015 Paris, France
[9] Hop Bicetre, INSERM, Unite 535, F-94276 Le Kremlin Bicetre, France
来源
ARCHIVES DE PEDIATRIE | 2003年 / 10卷 / 02期
关键词
lupus erythematosus systemic; diagnostic techniques and procedures; clinical protocols; child;
D O I
10.1016/S0929-693X(03)00313-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Systemic Lupus Erythematosus (SLE) remains a challenging autoimmune disease in term of etiology, pathogenesis and treatment. It is estimated that 10-17% of lupus patients present before the age of 16. SLE in children appears to have more severe organ involvement than in adults. The outcome of childhood SLE has improved during the last decade, but the morbidity remains high. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 83 条
[1]  
ABUDMENDOZA C, 1993, J RHEUMATOL, V20, P731
[2]   Vaccination and systemic lupus erythematosus: the bidirectional dilemmas [J].
Aron-Maor, A ;
Shoenfeld, Y .
LUPUS, 2001, 10 (03) :237-240
[3]   The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development [J].
Balomenos, D ;
Martín-Caballero, J ;
García, MI ;
Prieto, I ;
Flores, JM ;
Serrano, M ;
Martínez, C .
NATURE MEDICINE, 2000, 6 (02) :171-176
[4]  
Barr SG, 1999, ARTHRITIS RHEUM, V42, P2682, DOI 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO
[5]  
2-6
[6]   CLINICAL, SEROLOGIC, AND IMMUNOGENETIC STUDIES IN CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BARRON, KS ;
SILVERMAN, ED ;
GONZALES, J ;
REVEILLE, JD .
ARTHRITIS AND RHEUMATISM, 1993, 36 (03) :348-354
[7]  
BAUDOIN V, 1997, MED SCI FLAMMARION, P285
[8]   The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: A cross-sectional study [J].
Berube, C ;
Mitchell, L ;
Silverman, E ;
David, M ;
Saint Cyr, C ;
Laxer, R ;
Adams, M ;
Vegh, P ;
Andrew, M .
PEDIATRIC RESEARCH, 1998, 44 (03) :351-356
[9]   Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies [J].
Botto, M ;
Dell'Agnola, C ;
Bygrave, AE ;
Thompson, EM ;
Cook, HT ;
Petry, F ;
Loos, M ;
Pandolfi, PP ;
Walport, MJ .
NATURE GENETICS, 1998, 19 (01) :56-59
[10]   Risk factors for damage in childhood-onset systemic lupus erythematosus - Cumulative disease activity and medication use predict disease damage [J].
Brunner, HI ;
Silverman, ED ;
To, T ;
Bombardier, C ;
Feldman, BM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :436-444